Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?

Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?

Abstract Research question To determine whether the use of oral dydrogesterone (DYD) in luteal phase support (LPS) during an artificial cycle provides equivalent clinical and ongoing pregnancy, delivery and miscarriage rates as micronized vaginal progesterone (MVP) in oocyte donation recipients. Des...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Margaux Lorillon, Geoffroy Robin, Laura Keller, Emeline Cailliau, Clémence Delcourt, Virginie Simon, Christine Decanter, Sophie Catteau-Jonard
Materialtyp: Artikel
Språk:English
Publicerad: BMC 2024-12-01
Serie:Reproductive Biology and Endocrinology
Ämnen:
Dydrogesterone
Micronized vaginal progesterone
Luteal phase support
Embryo transfer
Intramuscular progesterone
Oocyte donation
Länkar:https://doi.org/10.1186/s12958-024-01322-7

Internet

https://doi.org/10.1186/s12958-024-01322-7

Liknande verk